Cargando…

Critical View of Novel Treatment Strategies for Glioblastoma: Failure and Success of Resistance Mechanisms by Glioblastoma Cells

According to the invasive nature of glioblastoma, which is the most common form of malignant brain tumor, the standard care by surgery, chemo- and radiotherapy is particularly challenging. The presence of glioblastoma stem cells (GSCs) and the surrounding tumor microenvironment protects glioblastoma...

Descripción completa

Detalles Bibliográficos
Autores principales:	Burster, Timo, Traut, Rebecca, Yermekkyzy, Zhanerke, Mayer, Katja, Westhoff, Mike-Andrew, Bischof, Joachim, Knippschild, Uwe
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Cell and Developmental Biology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8415230/ https://www.ncbi.nlm.nih.gov/pubmed/34485282 http://dx.doi.org/10.3389/fcell.2021.695325

Ejemplares similares

CK1δ in lymphoma: gene expression and mutation analyses and validation of CK1δ kinase activity for therapeutic application
por: Winkler, B. Sophia, et al.
Publicado: (2015)

Diisothiocyanate-Derived Mercapturic Acids Are a Promising Partner for Combination Therapies in Glioblastoma
por: Xu, Pengfei, et al.
Publicado: (2022)

Regulation of MHC I Molecules in Glioblastoma Cells and the Sensitizing of NK Cells
por: Burster, Timo, et al.
Publicado: (2021)

Metabolic Drivers of Invasion in Glioblastoma
por: Garcia, Joseph H., et al.
Publicado: (2021)

Research Progress of circRNAs in Glioblastoma
por: Guo, Xu, et al.
Publicado: (2021)

Immunomodulatory effects of extracellular vesicles in glioblastoma
por: Low, Johannes Jun Wei, et al.
Publicado: (2022)

Angiogenesis-Related Gene Signature-Derived Risk Score for Glioblastoma: Prospects for Predicting Prognosis and Immune Heterogeneity in Glioblastoma
por: Wang, Gang, et al.
Publicado: (2022)

Considering the Experimental Use of Temozolomide in Glioblastoma Research
por: Herbener, Verena J., et al.
Publicado: (2020)

Application of an Activity-Based Probe to Determine Proteolytic Activity of Cell Surface Cathepsin G by Mass Cytometry Data Acquisition
por: Gärtner, Fabian, et al.
Publicado: (2020)

Roles of Non-coding RNAs and Angiogenesis in Glioblastoma
por: Balandeh, Ebrahim, et al.
Publicado: (2021)

Therapeutic effect of natural polyphenols against glioblastoma
por: Beylerli, Ozal, et al.
Publicado: (2022)

Roles of STAT3 in the pathogenesis and treatment of glioblastoma
por: Fu, Weijia, et al.
Publicado: (2023)

Immune phenotypes predict survival in patients with glioblastoma multiforme
por: Mostafa, Haouraa, et al.
Publicado: (2016)

Obesity Prolongs the Inflammatory Response in Mice After Severe Trauma and Attenuates the Splenic Response to the Inflammatory Reflex
por: Gärtner, Fabian, et al.
Publicado: (2021)

Organoid Models of Glioblastoma to Study Brain Tumor Stem Cells
por: Azzarelli, Roberta
Publicado: (2020)

Ivacaftor Inhibits Glioblastoma Stem Cell Maintenance and Tumor Progression
por: Liu, Kun, et al.
Publicado: (2021)

Unveiling a Ghost Proteome in the Glioblastoma Non-Coding RNAs
por: Cardon, Tristan, et al.
Publicado: (2021)

The dark side of mRNA translation and the translation machinery in glioblastoma
por: Montiel-Dávalos, Angélica, et al.
Publicado: (2023)

Effects of glioblastoma-derived extracellular vesicles on the functions of immune cells
por: Musatova, Oxana E., et al.
Publicado: (2023)

Activity-Based Probes to Utilize the Proteolytic Activity of Cathepsin G in Biological Samples
por: Burster, Timo, et al.
Publicado: (2021)

Pentraxin 3 Promotes Glioblastoma Progression by Negative Regulating Cells Autophagy
por: Wang, Zeyu, et al.
Publicado: (2020)

SUMOylation Regulator-Related Molecules Can Be Used as Prognostic Biomarkers for Glioblastoma
por: Li, Xiaozhi, et al.
Publicado: (2021)

Identification and characterization of putative biomarkers and therapeutic axis in Glioblastoma multiforme microenvironment
por: Kumari, Smita, et al.
Publicado: (2023)

Evolving Insights Into the Biological Function and Clinical Significance of Long Noncoding RNA in Glioblastoma
por: Liu, Kun, et al.
Publicado: (2022)

VRK1 Depletion Facilitates the Synthetic Lethality of Temozolomide and Olaparib in Glioblastoma Cells
por: Navarro-Carrasco, Elena, et al.
Publicado: (2021)

Quaking but not parkin is the major tumor suppressor in 6q deleted region in glioblastoma
por: Aksoy Yasar, Fatma Betul, et al.
Publicado: (2022)

Lrig1 regulates the balance between proliferation and quiescence in glioblastoma stem cells
por: Ferguson, Kirsty M., et al.
Publicado: (2022)

Exogenous cathepsin G upregulates cell surface MHC class I molecules on immune and glioblastoma cells
por: Giese, Madleen, et al.
Publicado: (2016)

Epigenetic Deregulation of the Histone Methyltransferase KMT5B Contributes to Malignant Transformation in Glioblastoma
por: López, Virginia, et al.
Publicado: (2021)

Clinical Significance and Immune Landscape of a Pyroptosis-Derived LncRNA Signature for Glioblastoma
por: Xing, Zhe, et al.
Publicado: (2022)

Neuropilin-1 modulates the 3D invasive properties of glioblastoma stem-like cells
por: Kerhervé, Mathilde, et al.
Publicado: (2022)

Editorial: Cell Death and Targeted Cancer Therapies
por: Bagci-Onder, Tugba, et al.
Publicado: (2022)

Molecular and Clinicopathological Characterization of a Prognostic Immune Gene Signature Associated With MGMT Methylation in Glioblastoma
por: Zhao, Liang, et al.
Publicado: (2021)

DNA5mC Regulator-Mediated Molecular Clusters and Tumor Microenvironment Signatures in Glioblastoma
por: Yu, Xinyu, et al.
Publicado: (2022)

The Role of m6A Regulator-Mediated Methylation Modification and Tumor Microenvironment Infiltration in Glioblastoma Multiforme
por: Wang, Liang, et al.
Publicado: (2022)

RECQ1 Promotes Stress Resistance and DNA Replication Progression Through PARP1 Signaling Pathway in Glioblastoma
por: Zhang, Jing, et al.
Publicado: (2021)

Targeting the Urotensin II/UT G Protein-Coupled Receptor to Counteract Angiogenesis and Mesenchymal Hypoxia/Necrosis in Glioblastoma
por: Le Joncour, Vadim, et al.
Publicado: (2021)

Comprehensive analysis of the prognosis and immune infiltrates for the BET protein family reveals the significance of BRD4 in glioblastoma multiforme
por: Ye, Yintao, et al.
Publicado: (2023)

Extracellular Matrix Proteins Confer Cell Adhesion-Mediated Drug Resistance Through Integrin α(v) in Glioblastoma Cells
por: Yu, Qi, et al.
Publicado: (2021)

Differentiation Between Glioblastoma Multiforme and Metastasis From the Lungs and Other Sites Using Combined Clinical/Routine MRI Radiomics
por: Han, Yuqi, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_qbh0s0crc2nro9q5ccn1t03p3o